Stock CLDX CELLDEX THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Celldex Therapeutics, Inc.

Equities

CLDX

US15117B2025

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
37.75 USD -1.20% Intraday chart for Celldex Therapeutics, Inc. -5.88% -4.82%
May. 15 Celldex Therapeutics Reports First Patient Dosed in Phase 2 Skin Disorder Study MT
May. 15 Celldex Therapeutics, Inc. Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Prurigo Nodularis CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. CLDX Stock
  4. News Celldex Therapeutics, Inc.
  5. Official Publications
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW